Open company graph database — free web & API
ログイン

AccuScan Sciences

AccuScan Sciences Inc.別名AccuScan サイエンス別名AccuScan Sciences株式会社別名
銘柄コード
—
上場市場
—
国
—
従業員(単独)
—
関連会社
0
§01

基本情報

BASIC
所在地
521 Cottonwood Dr., Milpitas, CA 935035
社長
従業員数(単独)
従業員数(連結)
開始日
終了日
§02

サイト

1 DOMAINS
§03

事業内容

8
genetic testing servicesresearch collaboration on genetic diseasesdevelopment of new treatmentsdata sharing of anonymized health informationproviding genetic testing opportunities for patientsMedical researchDevelopment of new products, tests, or discoveriesClinical testing services
§04

関連会社

0 COMPANIES

—

§05

関連図

NETWORK
資本関係 得意先 仕入先 業務提携 銀行・株主 ドラッグで移動 · クリックで詳細へ
§07

ニュース

2 ARTICLES

AccuScan Shows MRD Data at AACR 2026 ↗

AccuScan Sciences announced interim data presented at the AACR Annual Meeting 2026 on its ultrasensitive whole-genome-sequencing-based ctDNA assay for postoperative MRD detection in colorectal cancer. The study evaluated 291 patients with Stage II–III disease and was conducted with Aarhus University researchers and Danish cancer centers.

Study on Ultra-Sensitive MRD Detection Published ↗

AccuScan Sciences announced that its peer-reviewed study, “Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction,” was published in EMBO Molecular Medicine. The study presents the AccuScan Whole Genome Sequencing assay, designed for ultra-sensitive detection of minimal residual disease in cancer patients.

§09

出典・更新

SOURCES
↑